drugset / Trial / NCT02857608

A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

NCT02857608

Phase 2 Withdrawn Cardinal Health 414, LLC
NaSingle-groupOpen-labelDiagnostic

Summary

Prospective, open-label, within-subject, multi-center pilot study of Lymphoseek in the detection of lymph nodes in subjects with known squamous cell carcinoma of the anus.

Timeline

Start
2016-09
Primary completion
2017-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 50 ug
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 18.5 mbq